Document is current
Any future updates will be listed below
-
Authors
Alushaj, Erind
Lowe, Michael https://orcid.org/0000-0001-5712-3800
Mollan, Susan P. https://orcid.org/0000-0002-6314-4437
Simpson, Sarah M.
Berman, Gabriele https://orcid.org/0009-0008-3390-9508
- License Information
-
More Information
Article History
Received: 25 February 2026
Revised: 3 March 2026
Accepted: 18 March 2026
First Online: 30 March 2026
Competing interests
: Michael Lowe reports speaker fees (Pfizer); travel (AbbVie, Teva, Lundbeck). Susan Mollan reports consultancy fees (Novo Nordisk); advisory board fees (Dompé Farmaceutici s.p.a, Sun Pharmaceuticals); speaker fees (Teva, AbbVie); Travel (AbbVie, Essilorluxottica, European Alliance of Associations for Rheumatology); Receipt of equipment (Heidelberg Engineering). Susan is a section editor at Eye Journal. Authors declare no other financial relationships with any organisations that might have an interest in the submitted work, and no other relationships or activities that could appear to have influenced the submitted work.
